Metallic stents and plastic endoprostheses in percutaneous treatment of biliary obstruction.
BACKGROUND
In the light of the clinical controversy whether metallic stents or plastic endoprostheses should be used in the percutaneous treatment of biliary obstruction we retrospectively evaluated our experience with both drainage-systems.


METHODS
71 patients (mean age 68 +/- 12 years) underwent a total of 81 interventions and received either plastic endoprostheses (11.5 or 12 French diameter; N = 57/81) or metallic stents (N = 24/81).


RESULTS
Drainage insertion was technically successful in all of the 71 patients. There was no procedure-related mortality, but a 30-day mortality of 15 % (N = 11). Overall, 27 complications occurred in 81 interventions with a statistically significant higher complication-rate in plastic endoprostheses (39 %; N = 21/54) compared to metallic stents (22 %; N = 6/27). The average patency of the drainage-systems was 166 +/- 341 days (range 1-2,705 days) and did not differ significantly between the drainage-subtypes. Incidence of complications and a further increase in serum bilirubin following intervention was associated with a higher drainage occlusion-rate and reduced survival, irrespective of the drainage-system used.


CONCLUSIONS
Percutaneous transhepatic treatment of biliary obstructions with internal drainages is a reliable therapy. The overall complication-rate of metallic stents was lower compared to plastic endoprostheses; however, no significant differences were found with respect to drainage patency or success-rate.
Beissert
M
M
Institut für Röntgendiagnostik, Universität Würzburg, Germany. beissert@roentgen.uni-wuerzburg.de
Wittenberg
G
G
Sandstede
J
J
Beer
M
M
Tschammler
A
A
Burghardt
W
W
Jahns
R
R
Hahn
D
D
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001650:Bile Duct Neoplasms / Q000097:blood / Q000401:mortality / Q000628:therapy*; D001663:Bilirubin / Q000097:blood; D002779:Cholestasis / Q000097:blood / Q000401:mortality / Q000628:therapy*; D005260:Female; D006801:Humans; D008297:Male; D008670:Metals; D008875:Middle Aged; D010166:Palliative Care; D010969:Plastics; D019736:Prostheses and Implants; D011474:Prosthesis Design; D011475:Prosthesis Failure; D012189:Retrospective Studies; D015607:Stents; D015996:Survival Rate; D016896:Treatment Outcome
D008670:Metals; D010969:Plastics; D001663:Bilirubin